JP2020099326A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020099326A5 JP2020099326A5 JP2019238469A JP2019238469A JP2020099326A5 JP 2020099326 A5 JP2020099326 A5 JP 2020099326A5 JP 2019238469 A JP2019238469 A JP 2019238469A JP 2019238469 A JP2019238469 A JP 2019238469A JP 2020099326 A5 JP2020099326 A5 JP 2020099326A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- region
- composition
- composition according
- egfr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019238469A JP7088902B2 (ja) | 2019-12-27 | 2019-12-27 | キメラ抗原受容体タンパク質をコードする核酸およびキメラ抗原受容体タンパク質を発現するｔリンパ球 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019238469A JP7088902B2 (ja) | 2019-12-27 | 2019-12-27 | キメラ抗原受容体タンパク質をコードする核酸およびキメラ抗原受容体タンパク質を発現するｔリンパ球 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017512081A Division JP6682509B2 (ja) | 2014-05-14 | 2014-05-14 | キメラ抗原受容体タンパク質をコードする核酸およびキメラ抗原受容体タンパク質を発現するｔリンパ球 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020099326A JP2020099326A (ja) | 2020-07-02 |
| JP2020099326A5 true JP2020099326A5 (https=) | 2020-12-17 |
| JP7088902B2 JP7088902B2 (ja) | 2022-06-21 |
Family
ID=71139019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019238469A Active JP7088902B2 (ja) | 2019-12-27 | 2019-12-27 | キメラ抗原受容体タンパク質をコードする核酸およびキメラ抗原受容体タンパク質を発現するｔリンパ球 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7088902B2 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108424454B (zh) | 2007-08-14 | 2022-05-31 | 路德维格癌症研究所有限公司 | 靶向egf受体的单克隆抗体175及其衍生物和用途 |
| PH12013501201A1 (en) | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| EP2694549B1 (en) | 2011-04-08 | 2018-08-15 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer |
| JP6850528B2 (ja) | 2012-02-13 | 2021-03-31 | シアトル チルドレンズ ホスピタル ドゥーイング ビジネス アズ シアトル チルドレンズ リサーチ インスティテュート | 二重特異性キメラ抗原受容体およびその治療的使用 |
| CN103382223B (zh) | 2012-04-01 | 2015-06-10 | 上海益杰生物技术有限公司 | 针对表皮生长因子受体隐蔽表位和t细胞抗原的多功能抗体多肽 |
-
2019
- 2019-12-27 JP JP2019238469A patent/JP7088902B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023085527A5 (https=) | ||
| US20240342283A1 (en) | ROR1 CAR or ROR1 / CD19 Dual CAR T Cells for the Treatment of Tumors | |
| JP2020506971A5 (https=) | ||
| JP2020517294A5 (https=) | ||
| JP2024023228A5 (https=) | ||
| JP2021512614A5 (https=) | ||
| RU2013104830A (ru) | Лечение рака при помощи направленных на мишень антител in vivo | |
| JP2016534717A5 (https=) | ||
| JP2018529327A5 (https=) | ||
| JP2022542543A (ja) | 抗ｄｌｌ３キメラ抗原受容体及びその使用 | |
| Murad et al. | Advances in the use of natural receptor-or ligand-based chimeric antigen receptors (CARs) in haematologic malignancies | |
| JP2017537620A5 (https=) | ||
| JP2015527070A5 (https=) | ||
| JP2009505676A5 (https=) | ||
| JP2018524300A5 (ja) | 組成物、抗体および結合性フラグメント | |
| RU2012123995A (ru) | Антитела, специфичные к клаудину 6 (cldn6) | |
| CN110072892A (zh) | Mg7，高度糖基化cea特异性结合的单链抗体及其在检测和治疗上的应用 | |
| RU2018104703A (ru) | Опухолеспецифичное антитело против egfr и его применение | |
| IL272103B1 (en) | Antigen binding proteins binding to 5T4 and 4-1BB and related compositions and methods of treating cancer | |
| CN115605513A (zh) | 一种抗pd-l1和her2的双特异性抗体 | |
| JP2021501567A5 (https=) | ||
| CN104628866A (zh) | 一种靶向vegfr2的抗体融合蛋白的制备及其用途 | |
| JP2020516668A5 (https=) | ||
| JP2014532706A5 (https=) | ||
| CN115916839A (zh) | 抗pdl1×egfr的双特异性抗体 |